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Urinary exosomes containing apical membrane and
intracellular fluid are normally secreted into the urine from all
nephron segments, and may carry protein markers of renal
dysfunction and structural injury. We studied methods for
collection, storage, and preservation of urinary exosomal
proteins. We collected urine from healthy volunteers, added
protease inhibitors, and stored urine samples at 4, 20, and
801C for 1 week or 7 months. Samples were thawed with
and without extensive vortexing, and three fractions were
isolated: urinary sediment, supernatant, and exosome
fraction. Protein concentration, electrophoresis patterns, and
abundance of seven exosome-associated proteins were
measured. Exosome-associated proteins were not detected in
sediment or supernatant fractions. Protease inhibitors
prevented degradation of exosome-associated proteins.
Freezing at 201C caused a major loss in exosomes
compared to fresh urine. In contrast, recovery after freezing
at 801C was almost complete. Extensive vortexing after
thawing markedly increased exosome recovery in urine
frozen at 20 or 801C, even if frozen for 7 months. The
recovery from first and second morning urine was similar.
The abundance of cytosolic exosome-associated proteins did
not decrease during long-term storage. We concluded: (1)
protease inhibitors are essential for preservation; (2) storage
at 801C with extensive vortexing after thawing maximizes
the recovery of urinary exosomes; (3) the difference between
first and second morning urine exosome-associated protein
was small, suggesting minimal protein degradation in the
urinary tract/bladder; (4) urinary exosomes remain intact
during long-term storage. These urine collection, storage,
and processing conditions may be useful for future
biomarker discovery efforts.
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Urine is an ideal non-invasive source of biomarkers to
diagnose and classify kidney diseases. New urinary biomar-
kers will likely help speed the laboratory and clinical
development of new treatments for renal diseases.1 Exosomes
containing vesicular membranes and intracellular fluid are
normally secreted into the urine from all nephron segments,
and contain proteins that may be altered in abundance or
physical properties in association with various renal diseases.
Pisitkun et al.2 successfully isolated exosomal membrane
proteins in fresh human urine by differential centrifugation
and demonstrated the presence of several disease-related
proteins. A previous study found that urinary Naþ /Hþ
exchanger isoform 3 (NHE3), a typical membrane protein,
increases in patients with acute renal failure.3 Thus, urinary
exosomal proteomics may provide an avenue for the
discovery of urinary biomarkers useful for early detection
of kidney diseases and for monitoring of treatment.4
However, how to store and preserve urinary exosomes
remains unclear. The aim of this study is to clarify effective
methods for the collection, storage, and preservation of
urinary exosomal proteins.
RESULTS
Effects of protease inhibitors
Samples obtained from healthy individuals were prepared
with and without protease inhibitors and processed as shown
in Figure 1. Western blot analysis of Na–K–Cl cotransporter
isoform 2 showed that the samples without protease
inhibitors had no signal or decreased signal compared to
the samples with protease inhibitors (Figure 2a and b).
Effects of storage and vortexing
Samples were pooled from three individuals, and then
processed in five different ways (see Materials and Methods,
Figure 1). Freezing at 201C caused a major loss of exosome-
associated protein measured by bicinchoninic acid protein
assay (27.4% recovery compared to urine stored at 41C). In
contrast, the recovery after freezing at 801C was 86%.
However, extensive vortexing after thawing resulted in 87.4%
and 100% recovery in urine frozen at 201C and 801C,
respectively (Figure 3a). These changes in exosome-asso-
ciated protein were verified using gel electrophoresis and
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Coommassie-blue staining (Figure 3b). Western blot analysis
showed that normal urine had easily detectable amounts of
NHE3, tumor susceptibility gene (TSG101), apoptosis-linked
gene-2 interacting protein X (ALIX), and aquaporin 2
(AQP2). In contrast, NHE3, TSG101, and ALIX could not
be detected, and less AQP2 was present in urine samples
frozen at 201C without vortexing after thawing. Freezing at
801C preserved almost all of the specific urinary exosome-
associated proteins. Extensive vortexing resulted in the
complete recovery of the above four specific urinary
exosome-associated proteins in pooled urine samples after
freezing at either 201C or 801C (Figure 3c).
To test if the exosme fraction could be isolated from
clinically relevant samples, we examined abundance of these
four specific urinary exosome-associated proteins in a much
smaller volume (10 ml) of fresh first morning urine from
three individual volunteers. Samples were normalized by
urinary creatinine (Ucr). We found that 10 ml of urine was
sufficient to detect these four specific urinary exosome-
associated proteins by Western blot analysis (Figure 4a lanes
1–3).
To determine the effect of long-term storage on the
recovery of the urinary exosome fraction, we examined the
abundance of the above four specific urinary exosome-
associated proteins (normalized by Ucr) in the individual
urine samples stored at 801C for 7 months. The results
showed that extensive vortexing also could result in almost
complete recovery of the above four specific urinary
exosomes compared to fresh urine samples (Figure 4a lanes
4–6). However, recovery of ALIX showed some variablity in
individual urine samples (Figure 4a).
To investigate whether storage at 801C can cause urinary
exosomes to rupture or remain intact, we examined the
abundance of two cytosolic proteins, neuron-specific enolase
(NSE) and malate dehydrogenase (MDH), which were
isolated from the exosome fraction in fresh urine and frozen
urine (801C for 7 months) from three individual volun-
teers. We hypothesized that cytosolic (internal) exosome-
associated proteins would not be detected if urinary
exosomes were damaged by prolonged freezing. We found
no difference in the abundance of NSE and MDH in urine
stored at 801C (for 7 months) compared to the fresh urine
samples (Figure 4b).
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Figure 1 | The isolation of three urinary fractions. Urinary sediment
(17 000 g pellet), exosome fraction (200 000 g pellet), and acetone
insoluble supernatant (17 000 g supernatant precipitated by acetone)
were isolated as described in Materials and Methods.
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Figure 2 | The effect of protease inhibitors. Eight fresh urine
samples were collected (a) without and (b) with protease inhibitors,
and exosome fractions were prepared and evaluated by Western
blotting for Na–K–Cl cotransporter isoform 2. Sample loading was
normalized by urine creatinine. B1–B8 and D1–D8 represent two sets
of different volunteers.
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Figure 3 | The effect of storage and vortexing. Samples were
pooled from three individuals. (a) Amount of urinary exosome-
associated protein (200 000 g pellet), (b) Coomassie blue-stained gel
of equal fraction volume of protein, (c) Western blot (10 ml aliquot) for
NHE3, TSG101, ALIX, and AQP2. a, b, and c: urine samples stored at 4,
20, and 801C without vortexing; d and e: urine samples stored at
20 and 801C with vortexing after thawing.
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Figure 4 | Effect of long-term storage. (a) Western blot of NHE3,
TSG101, ALIX, and AQP2 abundance in exosome fraction normalized
by urine creatinine from 10 ml freshly collected urine samples (lanes
1–3) or after long-term storage (801C for 7 months; lanes 4–6) from
three different individuals. Lanes 1 and 4, lanes 2 and 5, lanes 3 and 6
are from the same volunteer. (b) Western blot of cytosolic exosome-
associated proteins (NSE and MDH) normalized by urine creatinine in
fresh (lanes 1–3) and long-term stored (801C for 7 months; lanes
4–6) urine samples from three different individuals. Lanes as in (a).
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The effect of urine collection protocol
The exosome fraction accounted for only 3.070.6% of total
protein excreted in the urine, whereas the soluble protein
(supernatant fraction) contained 49.372.4% and the sedi-
ment fraction contained 47.772.5% of total protein excreted
in the urine (Figure 5). To determine if urine exosome-
associated proteins are stable during a prolonged overnight
collection, we compared overnight (first urine) and fresh
(second urine) collection methods. We used Ucr or urine
flow rate to normalize the gel loading of protein. The protein
staining patterns of 17 000 g urinary sediment pellets (Figure
6c and d) or 17 000 g urinary supernatant (Figure 6e and f)
are almost the same by using either normalization method.
However, some minor differences were seen in the 200 000 g
pellet (Figure 6a and b). Both the 200 000 g pellet and the
17 000 g urinary sediment were dominated by a single species,
presumably Tamm–Horsfall protein (THP). In contrast, the
17 000 g urinary supernatant had fewer bands with much less
THP in this fraction. The major band was presumably
albumin.
Specific urinary exosome-associated proteins were not
detected in all urinary fractions. Urinary exosome-associated
proteins (NHE3, TSG101, ALIX, and AQP2) were easily
detected only in the 200 000 g pellet (Figure 7), but not in
17 000 g urinary sediment or 17 000 g urinary supernatant by
Western blot analysis (data not shown).
First and second morning urine had similar amounts of
total protein in the three urinary fractions (Figure 5). The
protein patterns matching the change of total protein
amounts were verified by Coomassie blue-stained SDS/PAGE
(Figure 6a–f) after normalization. To investigate the effect of
protein degradation in bladder/urinary tract on urinary
exosomes, we compared the abundance of four specific
urinary exosmes by Western blot analysis. We found that the
abundance of four specific exosome-associated proteins
(TSG101, NHE3, ALIX, and AQP2) are similar between first
and second morning urine after normalizing by Ucr (Figure
7a) or urine flow rate (Figure 7b).
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Figure 5 | Protein contribution of three fractions to whole urine.
Protein contribution, expressed as protein content of unfractionated
urine. (a) Urinary exosome fraction (after 200 000 g 1 h spin); (b)
urinary sediment proteins (after 17 000 g 15 min spin); and (c)
supernatant proteins (after 17 000 g 15 min spin). Legend: (a), (b), and
(c) represent different volunteers, 1 (&): first morning urine, 2 (’):
second morning urine.
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Figure 6 | Protein electrophoretic patterns of three different
urinary fractions of human first and second morning urine. (a and
b) Coomassie blue-stained gels of urinary proteins in exosome
fraction after 200 000 g 1 h spin, (c and d) urinary sediment proteins
after 17 000 g 15 min spin, and (e and f) supernatant proteins after
17 000 g 15 min spin normalized by urinary creatinine (a, c, e) or urine
flow rate (b, d, f). Legend: a, b, and c represent different volunteers,
1: first morning urine, 2: second morning urine.
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Figure 7 | Specific exosome-associated proteins in first and
second morning urine. Abundance of NHE3, TSG101, ALIX, and
AQP2 by Western blotting in the urinary exosome fraction normalized
by (a) urinary creatinine or (b) urine flow rate. Legend: a, b, and c
represent different volunteers, 1: first morning urine, 2: second
morning urine.
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DISCUSSION
The results of the present study demonstrate that (1) protease
inhibitors are necessary for preservation of exosome-
associated proteins during urine collection process; (2)
freezing urine samples at 801C preserved urinary exo-
some-associated proteins better than at 201C; (3) extensive
vortexing after thawing improved recovery of the urinary
exosome fraction; (4) human urine exosome-associated
proteins were detectable in 10 ml urine samples; (5) first
and second morning urine can be used for exosome isolation.
Exosomes are secreted bioactive vesicles of 50–100 nm in
diameter, formed in late endocytic compartments (multi-
vesicular bodies). Currently, many features remain unclear
about exosomes, but research has begun to highlight their
potential physiological roles and clinical uses.5 Exosomes
have immunoregulatory roles and potent antitumor effects in
B lymphocytes and dendritic cells.6,7 Urinary exosomes are
the internal vesicles of multivesicular bodies that are
delivered to the urinary space by fusion of the outer
membrane of multivesicular bodies with the apical plasma
membrane of renal tubule epithelial cells.4 Pisitkun et al.2
first verified the existence of exosomes in human urine from
healthy subjects by electron microscopy and identified 295
proteins in urinary exosomes by proteomic analysis. Du
Cheyron3 reported that urinary NHE3, a typical apical
membrane protein, increases in patients with acute renal
failure (despite storage of urine samples at 201C, see
below). These results suggest that the urinary exosome-
associated proteins may serve as biomarkers for early
diagnosis and treatment of kidney diseases. However, before
proceeding with large-scale discovery efforts, there are a
number of important barriers that need to be overcome. The
first barrier is to determine how to effectively collect,
preserve, and recover urinary exosome-associated proteins.4
Numerous studies have reported the effect of storage
temperature on the individual major urinary proteins. Uto
et al.8 reported that storage at 701C did not alter the
concentration of THP compared to fresh urine, while storage
301C resulted in a three-fold increase of THP in human
urine. Innanen et al.9 found that one or two freeze–thaw
cycles decreased the concentration of microalbumin; how-
ever, mixing after thawing restored microalbumin concentra-
tion to normal. Klasen et al.10 reported that storage at 701C
is more stable than 201C for preserving urinary albumin,
transferrin, and globulin. The previous studies did not
address the collection, storage, and preservation of human
urinary exosome-associated proteins. In the present study, we
found that protease inhibitors are necessary to prevent the
degradation of exosome-associated proteins during collection
and processing steps. We found that freezing at 201C caused
a major loss of urinary exosome-associated proteins, whereas
801C storage only caused a mild loss (14%) of urinary
exosome-associated proteins. However, of greater impor-
tance, we found that extensive vortexing could restore to
normal the recovery of urinary exosome-associated proteins
in the urine frozen at 801C, and greatly improve the
recovery of urinary exosome-associated proteins even in
urine stored at 201C. In addition, we found that urinary
exosome-associated proteins were preserved almost comple-
tely after long-term storage at 801C although some
proteins, such as ALIX, maybe more labile. We hypothesize
that urinary exosomes may be trapped in a proteinous
meshwork and then co-precipitate with urinary constituents
such as THP, or attach to the wall of plastic tubes after
freezing. Eventually, extensive vortexing releases exosome-
associated proteins after thawing. Thus, long-term storage is
a viable option, despite initial losses, because urinary
exosomes can be recovered with extensive vortexing.
To evaluate collection procedures, we compared first and
second morning urine. We found that human first and
second morning urine are very similar with respect to total
protein in different urinary fractions (sediment, supernatant,
and exosomes) or exosome-associated proteins, suggesting
that there is only minimal degradation of urinary exosomes
in the bladder/urinary tract. Un-timed or spot urine
collections are more easily obtained than timed urine
collection in both in-patient and outpatient settings. In
theory, the best biomarker quantification scheme would
express biomarker excretion in units of mass excretion rate.
Since the excretion rate cannot be determined from a spot
urine sample, instead, a typical control for urinary concen-
tration is estimated by the Ucr concentration, which assumes
that creatinine excretion rate is constant. Assadi11 is found
that urinary microalbumin to creatinine ratios in second
morning urine correlated well with 24 h urine protein
excretion. Ginsberg et al.12 reported that the determination
of ratios of urinary protein to creatinine concentration in a
random single-voided urine sample during daytime activities
can replace the measurement of protein excretion in 24 h
urine collection. To our knowledge, this is the first report to
compare urinary exosome secretion between first and second
morning urine samples. Also, small clinically relevant urine
volumes (10 ml) are sufficient to detect urinary exosomal
markers.
Our results may appear to differ from those recently
reported by du Cheyron et al.3 They only found NHE3 in the
urinary exosome fraction from patients with acute renal
failure, but did not, in general, detect NHE3 in normal
subjects. In contrast, we could easily detect NHE3 in normal
subjects. However, du Cheyron et al. stored their urine
samples at 201C, and did not mention a vortexing step.
Thus, both studies agree that NHE3 is difficult to detect in
urine samples stored at 201C and processed without
vortexing. This highlights the critical importance of optimiz-
ing urine collection, storage, and processing conditions.
In additional to renal disease or injury, several variables
such as collection time, volume status, age, gender, nutri-
tional status, physical activity, etc. might modulate exosome
excretion and hence confound the comparison between
different groups of subjects. A uniform normalization
method is required to compare subjects with widely different
hydration states or urinary flow rates. Normalization by urine
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flow rate is theoretically the best method but it is rarely
practical; therefore, normalization by Ucr is currently the best
option for clinical study. With the isolation of urinary
exosomal biomarkers from spot urine collection, it may be
possible to collect urine samples to screen for kidney diseases
detection prognoses or guide treatment of known kidney
diseases. Also, wide range studies can be conducted in either
inpatients or outpatients to understand the pathophysiolo-
gical mechanisms of various kidney diseases by the biological
information included in urinary exosomes.
CONCLUSION
Recovery of urinary exosome-associated proteins is enhanced
by addition of protease inhibitors soon after collection,
storage at 801C, and extensive vortexing during thawing.
Spot urine can be normalized by urine creatinine or urine
flow rate. Urinary exosome-associated proteins can be
detected in clinically relevant urine samples (10 ml). The
difference between first and second morning urine protein
recovery was small, suggesting minimal protein degradation
in the urinary tract and bladder. These collection, storage,
and processing conditions of urinary samples may be useful
for future biomarker discovery efforts.
MATERIALS AND METHODS
Urine samples collection, storages, and handling
Human urine samples were collected under human subject research
protocols approved by Institutional Review Boards of NIDDK and
Universita¨tsklinikum C.G. Carus, Dresden, Germany. To each 50 ml
of urine, we added 4.2 ml of a protease inhibitor mixture (1.67 ml of
100 mM NaN3/2.5 ml of 10 mM PMSF/50:l of 1 mM Leupeptin).
Experiment 1: To confirm whether protease inhibitors are
necessary during the urine collection process. Spot urines were
collected with and without the above protease inhibitors from eight
healthy volunteers.
Experiment 2: Three samples of first morning urine were
collected from three healthy volunteers (aged 11–41 years, approved
Research Study No. 00-DK-0107) to study effective methods for the
storage and preservation of urinary exosomal proteins. Freshly
obtained urine samples (300 ml each) were pooled and then
subjected to five different protocols (100 ml per protocol in 50 ml
plastic centrifuge tubes): (a) stored at 41C and processed within 1 h;
stored at (b) 201C or (c) 801C for 1 week without vortexing
before use; stored at (d) 201C or (e) 801C for 1 week, subject to
extensive vortexing (90 s) after complete quick thawing. This
experiment was repeated twice. In addition, we stored three
individual urine samples at 801C for 7 months.
Experiment 3: First and second morning urine samples from
three separate individuals (120 ml each) were collected to investigate
the effects of urine collection time on urinary exosomes to assess
degradation of urinary exosomal proteins, and also to compare the
normalization methods for un-timed/spot urine samples. Urinary
creatinine was determined by ELISA kit (Exocell. Inc., Philadelphia,
PA, USA). This experiment was repeated three times.
Experiment 4: We processed 10 ml fresh first morning urine
samples from three individuals to verify whether the exosome
fraction could be isolated from much smaller volumes typical of
clinical samples.
Isolation of urinary proteins in exosome fraction
The urinary exosome fraction was prepared using the protocol of
Pisitkun et al.2 Urine was centrifuged at 17 000 g for 15 min at 41C to
remove urinary sediment including whole cells, large membrane
fragments, and other debris. An aliquot of the supernatant was
removed and the remaining supernatant was centrifuged at 200 000 g
for 1 h at 41C (L8-70M ultracentrifuge, Beckman Coulter, Inc.,
Fullerton, CA, USA; 70.1 Ti rotor) to obtain low-density
membranes. The 200 000 g supernatants were removed and replaced
with an additional 17 000 g supernatant and ultracentrifuged again.
This centrifugation step was repeated 3–5 more times to harvest the
low-density exosome pellets from 96 ml of 17 000 g supernatant.
Pellets were resuspended in 200:l of isolation solution (10 mM
triethanolamine/250 mM sucrose (pH 7.6); 0.5 mM PMSF; 1 mm
Leupeptin), and pooled. After removing 10:l for bicinchoninic acid
protein assay (Pierce, Rockford, IL, USA), the remaining suspension
was added to an equal volume of 2 Laemmli sample buffer
containing 60 mg/ml dithiotheritol and heated at 601C for 10 min.
These samples were divided into aliquots and stored at 801C until
use.
Some urine samples were fractionated as follows: (1) urinary
sediment (pellet after 17 000 g 15 min spin); (2) urinary supernatant
(supernatant after 17 000 g 15 min spin from 20 ml urine samples).
A 10 ml aliquot of 17 000 g supernatant was used to isolate urinary
protein by acetone precipitation described by Thongboonkerd
et al.13 The pellets from these two fractions were resuspended in
500 ml 1 Laemmli sample buffer. After removing 20:l of each
samples for 2-D quant protein assay (Amersham, Piscataway, NJ,
USA), dithiotheritol was added into each suspension (30 mg/ml)
and the samples were heated at 601C for 10 min. Aliquots were
stored at 801C until use (Figure 1).
Gel electrophoresis and Western blotting
The total amount of protein was calculated in each urinary fraction.
Loading amounts for gel electrophoresis were adjusted to equalize
either Ucr concentration or collection time (urine flow rate) for
individual urine samples to account for differences in urine
concentration or urinary flow rate. When pooling, a constant
proportion of each urine sample was added as specified in Results.
Protein samples were separated by 1D SDS/PAGE electrophoresis
and then stained by Colloidal Blue Staining kit (Invitrogen,
Carlsbad, CA, USA).
Duplicated gels were transferred to polyvinylidine difluoride
membranes for Western blotting. After blocking with 5% milk blot
(1 h), membranes were probed overnight at 41C with antibodies:
polyclonal antibodies to NHE3 (1:1000), AQP2 (1:2000), Na–K–Cl
cotransporter isoform 2 (1:1000),2 NSE (1:1000) (Biogenesis,
Kingston, NH, USA); monoclonal antibodies to TSG101 (1:1000)
(Abcam, Cambridge, MA, USA), or ALIX (1:250) (AIP1, BD
Bioscience, San Jose, CA, USA); sheep anti-MDH (1:4000) (Rock-
land, PA, USA). Peroxidase-conjugated, affinity-purified donkey
anti-rabbit, anti-mouse, or anti-sheep IgG (1:100 000) (Jackson
ImmunoReseach, West Grove, PA, USA) were used for 90 min at
room temperature. The antibody–antigen reactions were visualized
by using ECL plus Western blotting detection system (Amersham
Biosciences, Piscataway, NJ, USA) and light-sensitive film (Kodak
BioMax XAR).
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